BioCentury
ARTICLE | Financial News

Knight Therapeutics completes follow-on

December 30, 2016 9:58 PM UTC

Knight raised C$100 million ($74.9 million) through the sale of 10 million shares at C$10 in a follow-on underwritten by GMP Securities, Cormark Securities, Bloom Burton, CIBC World Markets, Laurentia...

BCIQ Company Profiles

Knight Therapeutics Inc.